Allahabad HC: Employees of Constituent Institutions are not Entitled to Central University Benefits  ||  Calcutta High Court: Juvenile Accused Eligible to Apply for Anticipatory Bail under Section 438 CrPC  ||  J&K & L HC: Departmental Proceedings Not Halted by Pending Criminal Case Without Showing Prejudice  ||  Cal HC: CESTAT Appeals Abate After Resolution Plan Success; CENVAT Reversal Requires No Pre-Deposit  ||  Bom HC: SEBI Settlement Doesn’t Protect Accused from Criminal Liability in Serious Economic Offences  ||  SC Directs States to Notify Eco-Sensitive Zones Around Tiger Reserves and Regulate Tiger Safaris  ||  SC: Its 2024 Order Letting Union Review Benami Act Cases Based on 'Ganpati Dealcom' was Incorrect  ||  SC: Rejection of Income Tax Settlement Application Doesn’t Bar Assessee from Contesting Assessment  ||  SC Informed Accessibility Facilities for Visually Impaired Candidates in AIBE and CLAT Expected Soon  ||  Supreme Court: Pendency of Writ Proceedings Does Not Bar Availing Alternative Statutory Remedies    

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE   EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved